Changing Neurodegenerative Disease Progression

Monthly Archives: July 2020

AZTherapies → Homepage-1 → 2020 → July

Search for:

AZTherapies Announces Closing of $33.6 Million Series C-1 Financing Building Upon Recent $37.5 Million Series C FinancingSeptember 29, 2020
AZTherapies Doses First Patient in Phase 2a Study of ALZT-OP1a in Amyotrophic Lateral Sclerosis (ALS)September 9, 2020
AZTherapies Announces the Appointment of Drs. Robert Malenka, Adam Boxer, Vijay Kuchroo and Megan Levings, to Scientific Advisory BoardAugust 11, 2020
AZTherapies Strengthens Board of Directors & Business Advisory Board with New AppointmentsJuly 22, 2020
Israel21c Profiles ALZT-OP1 and AZTherapies Founder David ElmalehJune 25, 2020